Publication:
The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents

Simple item page
dc.contributor.authorErgun, Tulin
dc.contributor.authorSeckin, Dilek
dc.contributor.authorBulbul, Emel Baskan
dc.contributor.authorOnsun, Nahide
dc.contributor.authorÖZGEN, ZÜLEYHA
dc.contributor.authorUnalan, Pemra
dc.contributor.authorALPSOY, ERKAN
dc.contributor.authorKARAKURT, SAİT
dc.date.accessioned2020-10-29T23:50:54Z
dc.date.available2020-10-29T23:50:54Z
dc.date.issued2015-05-01T00:00:00Z
dc.description.abstractBackgroundTumor necrosis factor-alpha (TNF-) antagonist treatment is associated with 1.6 to 27 times higher risk of tuberculosis (TB).
dc.identifier.citationErgun T., Seckin D., Bulbul E. B. , Onsun N., ÖZGEN Z., Unalan P., ALPSOY E., KARAKURT S., -The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents-, INTERNATIONAL JOURNAL OF DERMATOLOGY, cilt.54, ss.594-599, 2015
dc.identifier.doi10.1111/ijd.12628
dc.identifier.scopus84928362350
dc.identifier.urihttp://hdl.handle.net/20.500.12645/27019
dc.identifier.wosWOS:000353411800044
dc.titleThe risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents
dc.typeArticle
dspace.entity.typePublication
local.avesis.idde425b76-3013-4fc8-b7d6-df68af1b5456
local.indexed.atWOS
local.indexed.atScopus
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files

Collections

Yayınlar - Eserler